Italian study tests daily pill to tame debilitating migraines
NCT ID NCT06414044
Summary
This study is observing how well a daily medication called atogepant works to prevent migraine attacks in real-world settings. It will follow 500 people in Italy with episodic or chronic migraines for up to two years, tracking how many headache days they have and how the treatment affects their daily life. The goal is to see if the benefits seen in earlier controlled trials hold up in everyday practice and to monitor side effects over a longer period.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fondazione Policlinico Campus Bio-Medico
Roma, 00128, Italy
-
SOD Centro Cefalee e Farmacologia Clinica, AOU Careggi
Florence, 50134, Italy
Conditions
Explore the condition pages connected to this study.